Literature DB >> 33005011

Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease.

Yi Zhou1,2, Zhimin Liu1,3, Ernest C Lynch1, Leya He1,2, Henghui Cheng1,2, Lin Liu1, Zhen Li1, Jiangyuan Li4, Lauren Lawless1, Ke K Zhang1,5, Linglin Xie6.   

Abstract

Odd-skipped related 1 (Osr1) is a novel tumor suppressor gene in several cancer cell lines. Non-alcoholic steatohepatitis (NASH) is considered as a high-risk factor for hepatocellular carcinoma (HCC). This study is aimed to investigate the novel role of Osr1 in promoting the progression of hepatic steatosis to NASH. Following 12 weeks of diethylnitrosamine (DEN) and high-fat diet (HFD), wildtype (WT) and Osr1 heterozygous (Osr1+/-) male mice were examined for liver injuries. Osr1+/- mice displayed worsen liver injury with higher serum alanine aminotransferase levels than the WT mice. The Osr1+/- mice also revealed early signs of collagen deposition with increased hepatic Tgfb and Fn1 expression. There was overactivation of both JNK and NF-κB signaling in the Osr1+/- liver, along with accumulation of F4/80+ cells and enhanced hepatic expression of Il-1b and Il-6. Moreover, the Osr1+/- liver displayed hyperphosphorylation of AKT/mTOR signaling, associated with overexpression of Bcl-2. In addition, Osr1+/- and WT mice displayed differences in the DNA methylome of the liver cells. Specifically, Osr1-responsible CpG islands of Ccl3 and Pcgf2, genes for inflammation and macrophage infiltration, were further identified. Taken together, Osr1 plays an important role in regulating cell inflammation and survival through multiple signaling pathways and DNA methylation modification for NAFLD progression.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33005011      PMCID: PMC7987871          DOI: 10.1038/s41374-020-00493-2

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  50 in total

Review 1.  Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.

Authors:  Soo Lim; Tae Jung Oh; Kwang Kon Koh
Journal:  Int J Cardiol       Date:  2015-08-10       Impact factor: 4.164

2.  c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: Multiple roles in multiple steps.

Authors:  Yuzo Kodama; David A Brenner
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

3.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

Review 4.  JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.

Authors:  Giovanni Tarantino; Armando Caputi
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

Review 5.  Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

6.  Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.

Authors:  Harmeet Malhi; Steven F Bronk; Nathan W Werneburg; Gregory J Gores
Journal:  J Biol Chem       Date:  2006-02-27       Impact factor: 5.157

Review 7.  Extrahepatic complications of nonalcoholic fatty liver disease.

Authors:  Matthew J Armstrong; Leon A Adams; Ali Canbay; Wing-Kin Syn
Journal:  Hepatology       Date:  2014-01-16       Impact factor: 17.425

Review 8.  Pathogenesis of nonalcoholic steatohepatitis.

Authors:  Wensheng Liu; Robert D Baker; Tavleen Bhatia; Lixin Zhu; Susan S Baker
Journal:  Cell Mol Life Sci       Date:  2016-02-19       Impact factor: 9.261

Review 9.  JNK regulation of hepatic manifestations of the metabolic syndrome.

Authors:  Mark J Czaja
Journal:  Trends Endocrinol Metab       Date:  2010-10-01       Impact factor: 12.015

Review 10.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

View more
  3 in total

1.  Transcriptomic Analysis Identifies Differentially Expressed Genes Associated with Vascular Cuffing and Chronic Inflammation Mediating Early Thrombosis in Arteriovenous Fistula.

Authors:  Vikrant Rai; Devendra K Agrawal
Journal:  Biomedicines       Date:  2022-02-13

2.  Disrupting Osr1 expression promoted hepatic steatosis and inflammation induced by high-fat diet in the mouse model.

Authors:  Ernest C Lynch; Zhimin Liu; Lin Liu; Xian Wang; Ke K Zhang; Linglin Xie
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

Review 3.  mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease.

Authors:  Jiayao Feng; Shuting Qiu; Shipeng Zhou; Yue Tan; Yan Bai; Hua Cao; Jiao Guo; Zhengquan Su
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.